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HIV-associated immune-mediated renal disease. Although focal gb-
merulosclerosis is the most common renal disease, other proliferative
gbomerulonephritides are encountered in HIV-infected patients. We
studied four HI V-infected patients with renal insufficiency, proteinuria,
and proliferative glomerulonephritis, consistent with immune-mediated
disease, to investigate the role of the virus and immune complexes in
the pathogenesis of the nephropathy. Circulating immune complexes
(CICs) and HIV-reactive antibodies were measured and characterized
in each patient. Renal biopsy tissue was acid eluted, and the eluate
analyzed. DNA extracted from biopsies was subjected to the poly-
merase chain reaction (PCR) to detect HIV genome. CICs were
detected in each patient: an IgA-p24 HIV antigen complex and an IgG
antibody-gp 120 HIV antigen complex in two patients; two patients had
an IgG-p24 HIV antigen complex. Identical complexes were eluted
from renal tissue in the first three patients; p24 HIV antigen, and
complement from the fourth. The eluted antibodies reacted with the
HIV antigens from the isolated CICs. Direct immunofluorescence for
viral antigen in the eluted gbomerular tissue revealed HIV antigens;
PCR confirmed the presence of gag genome in all four biopsies. We
conclude both circulating and in-situ HIV antigen-specific immune
complexes may be associated with glomerulonephritis in HIV infected
patients. Viral incorporation into renal tissue may be important in the
pathogenesis of HIV-associated renal disease.
Several renal syndromes have been described in patients with
HIV infection [1—7]. Patients with chronic renal insufficiency
and nephrotic syndrome associated with HIV infection often
have focal and segmental glomerulosclerosis [1—5, 8—10]. Some
investigators have suggested this finding constitutes a distinct,
clinico-pathological entity, termed either AIDS-associated or
HIV-associated nephropathy [1, 2, 4, 8, 9]. In contrast, how-
ever, other histological findings such as membranoproliferative
and diffuse proliferative glomerulonephritis [6, 11, 12], mem-
branous glomerulonephritis [13], and IgA nephropathy [14—17],
noted in patients with HIV infection and chronic renal dysfunc-
tion or nephrotic syndrome [1—3] all possess pathological char-
acteristics strongly suggestive of an immune-mediated etiology.
Recent biopsy series in patients with HIV infection and renal
disease have suggested that approximately one-quarter to one-
half of patients may have glomerulonephritis [18, 19]. Since
HIV-related antigen-antibody complexes have been demon-
strated in the circulation of HIV infected patients [20—22], it is
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unclear whether these pathologic findings relate to immune
complex deposition, the formation of in-situ complexes, infec-
tious complications of HIV infection, manifested as post-
infectious glomerulonephritis [12], or to other, as yet unknown,
mechanisms.
We studied four patients with HIV infection, proteinuria and
renal insufficiency in whom the renal pathologic findings were
consistent with immune-mediated glomerulonephritis. HIV-
associated antigen-antibody complexes were recovered from
the circulation of all four patients, and identical complexes were
recovered and identified from eluates of renal tissue in three of
the four. In all four of the patients' biopsy material HIV
antigens could be immunologically detected within glomeruli,
and polymerase chain reaction (PCR) examination confirmed
the presence of HIV genome in the renal tissue.
Methods
Case reports
Patient 1. A 31-year-old Black homosexual male had HIV
infection for two years prior to an increase in serum creatinine
concentration from 88.4 to 283 mol/liter over a year, four
months before admission. He had Pneumocystis carinii pneu-
monia two years prior to admission, treated with sulfamethox-
azole-trimethoprim. Zidovudine, started at the time of the
diagnosis of HIV infection, was discontinued six months prior
to admission. Mycobacterium avium intracellulare lymphade-
nitis was diagnosed one year prior to admission. Medications at
the time of evaluation consisted of pentamidine, nadolol, rani-
tidine, triamterene-hydrochlorthiazide, hydroxyzine hydro-
chloride, terfenadine and triazolam. There was no history of
transfusions, intravenous drug use, or family history of kidney
disease.
Physical examination revealed BP of 130/100 mm Hg, a clear
chest examination and no edema. There was bilateral axillary
adenopathy and a diffuse hypopigmented rash. Urinalysis re-
vealed 4+ proteinuria, trace hematuria, pH 6.0. Two to three
tubular epithelial cells, and rare granular and cellular casts per
high power field were seen on microscopic exam. Serum urea
and creatinine concentrations were 38.6 mmo!/!iter and 928
.&mollliter, respectively. Creatinine clearance was 0.12 mI/sec;
there was 10.2 g non-selective urinary protein excretion/day. A
complete blood count revealed a hematocrit of 32.4%, platelet
count 205 x 109/liter, and 5.4 x 109/liter leukocytes. There was
lymphopenia with an absolute CD4 count of 6/pi, (normal >
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400/id), low percentage of CD4 positive cells (1%), and an
extremely diminished CD4ICD8ratioof 0.02 (normal 1.0 to 2.2).
Serum electrolyte concentrations were within normal limits.
Serum aspartate and alanine aminotransferase (AST and ALT)
levels were slightly elevated, but bilirubin and alkaline phos-
phatase levels were normal. Serum protein electrophoresis
revealed diminished total protein and albumin levels but in-
creased alpha globulins. There was no monoclonal spike.
CH5O, C'3 and C'4 levels were either normal or slightly
increased. Serologic tests for syphilis were strongly positive.
Hepatitis B virus surface antigen was negative, but hepatitis B
surface and core antibody and hepatitis C virus antibody
screens were positive.
Patient 2. A 55-year-old Black male presented with a one
month history of pedal edema, fatigue, and nocturia, and a two
week history of nausea, vomiting and a 10 pound weight loss.
Two years prior to evaluation the patient had normal renal
function. He had taken ibuprofen over the previous three
weeks. Evaluation revealed serum creatinine concentration of
433 xmolIliter, creatinine clearance 0.42 mI/sec, and 29.4 g
urinary protein excretion/day. Serum protein electrophoresis
revealed diminished total protein concentration, with severe
hypoalbuminemia, normal alpha 1, 2, and beta globulin levels,
and elevated gamma globulin concentration. Antinuclear anti-
body, antistreptolysin 0 serology, latex fixation, hemoglobin
AIC percentage, C'3 and C'4 were either negative or within
normal limits. The patient had had an oligoclonal gammopathy
for two years. There was a history of mitral regurgitation and
paroxysmal supraventricular tachycardia, treated with dilt-
iazem, longstanding well-controlled hypertension, most re-
cently treated with verapamil, and gout. There was no history
of opportunistic infection. The patient was bisexual, and denied
use of intravenous drugs. There was a family history of diabetes
and kidney disease.
Physical examination showed BP of 140/100 mm Hg, fundi
with rare hemorrhages and arteriovenous nicking, an apical
holosystolic murmur, and trace pedal edema. Urinalysis re-
vealed specific gravity 1.020, pH 6.0, glucosuria, proteinuria,
rare amorphous crystalluria and glitter cells. Serum urea and
creatinine concentrations were 11.4 mmollliter and 451 xmol/
liter respectively. Complete blood count revealed 7.5 x l09/liter
leukocytes, hematocrit of 30%, platelet count 251 X 109/Iiter.
Absolute lymphocyte count was within normal limits and the
absolute CD4 count was 488/1.d, but the percentage of CD4
positive cells was diminished (helper/suppressor ratio of 0.4).
Serum electrolyte concentrations were within normal limits.
AST and ALT levels were slightly elevated, but bilirubin and
alkaline phosphatase levels were normal. ELISA screen for
H!V was positive, confirmed by Western blot analysis. Sero-
logical tests for syphilis were negative. Hepatitis B virus
surface and A virus antibody screens were negative, but hepa-
titis B core antibody was positive. Cytomegalovirus titers were
markedly elevated. Anti-double stranded DNA antibody titer
was slightly elevated but anti-single stranded DNA antibody,
Sm and RNP antigens were within normal limits or negative.
Patient 3. A 44-year-old Black male had proteinuria and
hematuria discovered two months after the diagnosis of HIV
infection was made. He had known of HIV infection for two
years before the renal evaluation. He denied homosexual
encounters, but had had sexual relations with prostitutes. He
had been asymptomatic, but a routine urinalysis revealed
hematuria. Creatinine clearance was 1.07 mI/sec and urinary
protein excretion was 0.3 g/day. He had a fifteen year history of
hypertension, treated with various medication regimens, and
had syphilis diagnosed and treated fourteen years prior to
evaluation. Ulcerative colitis was diagnosed seven years prior
to evaluation, but had been well-controlled after treatment.
Medications at the time of evaluation were zidovudine, azulfi-
dine, nadolol, triamterenelhydrochlorthiazide and sulfamethox-
azole/trimethoprim.
Physical examination revealed BP of 150/100 mm Hg, hyper-
tensive retinopathy, and bilateral axillary adenopathy. There
was no edema. Urinalysis revealed pH 6.0, 3+ proteinuria, and
10 to 20 red blood cells per high power field, without red blood
cell casts. Serum urea and creatinine concentrations were 7.5
mmol/liter and 115 xmolJliter, respectively. Complete blood
count revealed 5.1 x 109/liter leukocytes, hematocrit of 37.4%,
platelet count 236 x 109/Iiter. Absolute lymphocyte count was
within normal limits, but there was a relative lymphocytosis.
The absolute CD4 count was 183/j,d. The percentage of CD4
positive cells was diminished (6%) and the helper/suppressor
ratio was 0.08.
Serum electrolyte, ALT and AST, bilirubin and alkaline
phosphatase concentrations were within normal limits. Creati-
nine clearance was 1.22 mI/sec. Urinary protein excretion was
1.4 g/day. Serological tests for syphilis were positive. Hepatitis
C virus and hepatitis B virus surface antigen serologies were
negative, but hepatitis B core antibody screen was positive. C'3
and C'4 concentration were at the lower level of normal. Serum
protein electrophoresis showed mild hypoalbuminemia and
increased total gamma globulin concentration, beta-gamma
bridging and oligoclonal banding. IgA, IgG and 1gM levels were
all increased. There was no evidence of cryoprecipitation.
Urinary protein electrophoresis was consistent with selective
proteinuria. There were no monoclonal bands present.
Patient 4. A 35-year-old Black homosexual man had HIV
infection for three years. He was treated for two years with
zidovudine, which was discontinued nine months before eval-
uation because of hematologic complications. Two months
before evaluation he complained of intermittent bilateral pedal
edema. His serum creatinine concentration increased from 124
mol/liter nine months prior to admission to 256 xmol/liter two
months prior to admission. Past medical history was remark-
able for candida esophagitis, E. coli urinary tract and Giardia
lamblia gastrointestinal infections and recurrent sinusitis. He
had been treated in the past with steroids for allergic dermatitis.
There was a history of epididymitis. There was a family history
of renal failure. He was taking furosemide and acetaminophen/
oxycodone at the time of evaluation.
Physical examination revealed BP of 110/70 mm Hg. He was
afebrile, and had scant rales at the right base. There was a
systolic murmur at the lower left sternal border, and marked
bilateral lower extremity edema. Urinalysis revealed specific
gravity 1.013, pH 5.0, protein concentration greater than 3
glliter. There was no glucosuria, ketonuria or bilirubinuria.
Microscopic examination revealed a few red and white blood
cells per high power field and scattered granular casts. Twenty-
four-hour urinary protein excretion was greater than 3 g/day.
Serum urea and creatinine concentrations were 30 mmol/Iiter
and 602 jxmol/Iiter, respectively. Creatinine clearance was 0.11
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mi/sec. Complete blood count revealed 5.0 x 109/liter leuko-
cytes, hematocrit of 21%, platelet count 1012 x 109/liter. There
was absolute lymphopenia. CD4 count was 18/pi, with a reduc-
tion in both the percentage of CD4 positive cells (4%) and the
helper/suppressor ratio (0.1).
Serum sodium concentration was 135 mmol/Iiter, potassium
5.1 mmol/liter, chloride 113 mmol/liter, bicarbonate 12.7 mmol/
liter. Serum albumin concentration was 14 g/liter. AST level
was slightly elevated, but biirubin was normal. Alkaline phos-
phatase level was markedly elevated. Hepatitis B core antibody
and CMV titers were positive. C'3 was 0.7 g/liter (normal 0.8 to
2.0 gfliter) but C'4 concentration was slightly above normal
limits. Serum protein and immunoelectrophoresis showed de-
creased alpha 1, beta, and total gamma globulin concentration
and an IgG kappa monoclonal band. IgG and IgA levels were
normal, but 1gM concentration was slightly decreased. Antinu-
clear antibody screens and rheumatoid factor evaluation were
negative.
All patients underwent renal biopsy after informed consent
was obtained. These studies were approved by the George
Washington University Medical Center Committee on Human
Research.
Histopathology
Paraffin embedded sections were stained for routine light
microscopy with hematoxylin-eosin, periodic acid Schiff, peri-
odic acid methenamine silver, Masson's trichrome and Congo
red [16]. Immunopathologic studies were performed on frozen
sections using fluorescein-conjugated monoclonal antibodies
(Dako Corp, Santa Barbara, California; Chemicon International
Inc., Temecula, California, USA), directed against albumin,
fibrinogen, C'lq, C'3, properdin, IgA, IgE, IgG, 1gM, and
kappa and lambda light chains. Osmium-treated epon-embed-
ded sections of glutaraldehyde-fixed tissue were examined with
electron microscopy [16].
Detection of HI V antibodies
Patients' plasma samples were screened for the presence of
anti-HIV antibodies by ELISA (Organon Teknika Corp.,
Durham, North Carolina, USA) and positive reactions con-
firmed by Western blot analysis (BioRad Laboratories, Rich-
mond, California, USA). Reactive anti-HIV antibodies were
classified using monospecific, peroxidase-labelled rabbit anti-
bodies directed against human IgA, IgG, and 1gM in the
secondary phase of the blot (Chemicon International, Inc.) [16].
Circulating immune complex detection and isolation
Circulating immune complexes (CICs) were measured by a
solid-phase C' lq Enzyme Immunoassay kit (Cytotech, San
Diego, California, USA), according to the manufacturer's in-
structions and isolated by a previously described polyethylene
glycol (PEG) precipitation- sedimentation technique [23]. Fol-
lowing isolation, each CIC was recovered, washed in cold PEG,
and dissolved in 0.01 M phosphate buffered saline, pH 7.2
(PBS), prior to analysis of the immunoglobulin content by single
radial immunodiffusion using commercially available plates
(Kallstad, Austin, Texas, USA).
Western blot analysis of CIC antigens
Each PEG-isolated CIC was denatured in SDS and separated
on a 10% T, 2.7% C PAGE gel at 40 mA for four hours, using
0.025 M Tris/0. 192 M glycine, pH 8.4, as the running buffer. The
separated gel maps were blotted to nitrocellulose and incubated
overnight at 4°C with 1:1000 dilutions of murine antibodies
directed against HIV p18, p24, gp4l, p55, p51/56, gpl2O and
gpl6o antigens (Epitope, Inc., Beaverton, Oregon, USA). An-
tibody localization was visualized by incubation with a 1:500
dilution of alkaline phosphatase-labeled rabbit anti-mouse IgG
followed by a 30 minute development in 0.2 mg/mI nitroblue
tetrazolium-0.04 mg/ml 5-bromo-4-chloro-3-indolyl phosphate
[24]. Non-immune murine IgG, from the same fusion partners,
and specific absorption of the anti-HIV antibodies with the
appropriate antigen were used as specificity controls.
Dot-blot analysis of urine
Urine samples from each patient were concentrated fifty
times by negative pressure dialysis prior to placing 20 d
aliquots into each of seven wells in a BioDot dot-blot apparatus
(Bio-Rad Laboratories) [25]. The samples were allowed to
diffuse onto a nitrocellulose membrane for 18 hours at 4°C
before incubating them for 18 hours with 100 td of a 1:1000
dilution of mouse monoclonal anti-HIV p18, p24, gp4l, p55,
pSi/S6. gpl2O and gpl6O (Epitope, Inc.). Bound antibodies were
detected as described above in the Western blot procedure and
identical specificity controls were incorporated.
Elution of kidney biopsies
Six m thick frozen sections of the patients' renal biopsy
material were acid eluted in 50 1.d 0.33 M citric acid, pH 2.0 per
section, for 17 hours at 4°C [26]. Eluates were sampled at 0, 1,
4, 8, and 17 hours and separated by block electrophoresis, using
1% SeaKem HEEO agarose (FMC BioProducts, Rockland,
Maine, USA). Anodal and cathodal migrating materials were
recovered, dialyzed against PBS and concentrated fivefold prior
to PAGE separation and Western blot analysis. Antibodies and
antigens recovered from the 17-hour elution samples were
reconstituted in SO d of normal human serum, which had
previously been shown to be CIC negative by the C' lq assay
and retested to assess the degree of enrichment caused by the
renal deposition. C'3 levels were measured in the plasma and in
separated renal eluates as an additional enrichment marker.
Immunochemical analysis of eluzed and complexed materials
Isolated antigens from both biopsy eluates and CICs were
separated by PAGE, blotted to nitrocellulose and immuno-
chemically stained with anti-HIV monoclonal antibodies. Iso-
lated antibodies from the same material were reacted against
blotted PAGE maps of whole HIV using 1:500 dilutions of
enzyme-labeled rabbit anti-human antisera as reporter reagents.
In addition, the immunoreactivity of the antibodies was tested
by immunodiffusion in 1% SeaKem LE agarose (FMC BioProd-
ucts) plates. Each gel pattern consisted of a central well (5 mm
diameter) surrounded by six equidistant peripheral wells (2 mm
diameter). Twenty-five p.1 of antibody isolated from either the
renal eluate or the CIC were placed into the central well and 10
p.1 of the eluate antigen, the CIC antigen, the urine antigen,
normal renal tissue extract, and two PBS controls were placed
1330 Kimmel et a!: HI V-immune complex glomerulonephritis
in the peripheral wells. The plate was placed in a moist chamber
and examined at 24, 48, and 72 hours.
immunocytochemical localization of intracellular HIV
antigens in eluted biopsy sections
The eluted sections from each patient's renal biopsy were
stained with rhodamine-labeled anti-human IgA, IgG, 1gM, C'3
and C'4 (Chemicon International, Inc.), to check the efficiency
of the elution. The sections from each biopsy were then stained
with fluorescein-labeled anti-HIV antibodies (Epitope, Inc.)
and the sections examined for the presence of intracellular HIV
antigens using laser-enhanced fluorescence microscopy (Merid-
ian Instruments, Inc., Okemos, Michigan, USA). The sections
were scanned at 250 diameters magnification and the images of
the glomerulus captured by a charged coupled device camera
and viewed as a computer-enhanced 256 gray-scale map. This
map was analyzed by the instrument's analytical software.
Following background subtraction, morphological areas dem-
onstrating high intensity staining were re-examined at 400x
power. The fluorescent image was photographed directly using
Polaroid 665 film.
Polymerase chain reaction
Five sm thick histologic sections of renal biopsy tissue from
the patients and from a control HIV-negative patient with
glomerulonephritis were scraped from glass slides. The DNA
was extracted using a modification [27] of the method of Saiki et
al [28] and subjected to a nested PCR, briefly described below,
in order to amplify target sequences within the gag and env
regions of the HIV-1 proviral genome. The tissue from the
patients and the various controls were processed in a parallel
manner. To assure the presence of tissue and that the reaction
was not inhibited by the sample, a region from exon I of the
human cardiac myosin heavy chain (MyHC) gene was co-
amplified with the gag and env genes in both the inner and outer
nests. The primers used for the amplification of the gag gene
were SK100 and SK1O5 for the outer nest, and SK18 and SK 39
for the inner nest. The primers used for the amplification of the
env gene were SK 68 and SK 69 for the outer nest, and SK 682
and SK 692 for the inner nest. For the MyHC gene, MHC1 and
MHC2 were used in the outer nest, and MyHC2O and MyHC4O
were used for the inner nest. The amplification reaction for the
outer and inner nests was repeated forty times. Each cycle
consisted of denaturation for one minute at 92°C, annealing for
two minutes at 52°C, and extension for three minutes at 72°C,
resulting in amplification of a fragment of 137 bps for the gag
gene, 79 bps for the env gene, and 185 bps for the MyHC gene.
After liquid hybridizing the inner nest reaction product with an
end labeled probe (SK19 for the gag gene, SK 689.1 for the env
gene and MyHC3O for the MyHC gene), the samples were run
on a 10% polyacrylamide gel, using PhX as a molecular weight
marker. The gels were exposed to X-ray film for the visualiza-
tion of bands. Several control samples were amplified simulta-
neously with the DNA from the patient's renal biopsies, includ-
ing a reagent control that contained no DNA template, a
negative control sample containing DNA known to be negative
for HIV-1 proviral DNA, and dilutions of a plasmid containing
a 9 kb fragment of the HIV-1 target genome, as a positive
control.
All primers and probes were synthesized in an oligonucleo-
tide synthesizer (Milligen-Biosearch Cyclone, Bedford, Massa-
chusetts, USA) using phosphoramitide based chemistry [28].
Results
Histopathology
Patient 1. Of the 25 glomeruli found in the biopsy, one was
normal, and two showed mild to marked mesangial expansion,
prominent visceral epithelial cells, and cellular crescents (Fig.
lA). The rest were obsolescent. There was microcystic tubular
dilation and atrophy, interstitial fibrosis and interstitial infiltra-
tion of lymphocytes and plasma cells. Immunofluorescent mi-
croscopy showed faint intramembranous deposits of IgA, C'3
and albumin, but when the sections were etched by trypsin
digestion for 10 minutes at 37°C, staining for IgA, C'3, C'4 and
albumin was seen. In addition, the etching revealed faint IgG
staining at the periphery of the tubules. Electron microscopy in
two obsolescent glomeruli showed the presence of finely gran-
ular, subendothelial and intramembranous electron dense de-
posits (Fig. 2A). Tubular reticular structures were not identified
in obsolescent glomeruli.
Patient 2. Six of twelve glomeruli showed increased cellular-
ity with lobular transformation, segmental consolidation of the
tuft, and synechiae. A few obsolete glomeruli with fibrocellular
crescents were also present. Peripheral capillary loops in unin-
volved segments appeared normal. In some glomeruli, segmen-
tal increase of mesangial cells and matrix was prominent (Fig.
1B), while in others sclerosis of tuft, including total obsoles-
cence were noted. Masson's trichrome stain revealed mesangial
deposits. There were scattered dense interstitial collections of
mononuclear cells, mostly lymphocytes and plasma cells, ac-
companied by polymorphonuclear leukocytes and eosinophils.
The tubular epithelium was permeated by inflammatory cells,
resulting in tubular destruction. Microcystic tubular dilation
was present, as were foci of tubular atrophy, periglomerular
and interstitial fibrosis. Immunofluorescence of the single avail-
able glomerulus revealed 1gM and C'3 present in abundance as
coarse granular mesangiaf deposits. Properdin and C'lq were
present in small amounts in mesangial granular deposits and
albumin and IgG were present within the proximal tubular
epithelium. There was insufficient glomeruli-containing tissue
for trypsin etching and immunoperoxidase studies. Electron
microscopy of one glomerulus, indicated as slightly abnormal
on light microscopy, showed glomerular basement membrane
of normal thickness and composition. There were no peripheral
intramembranous or subepithelial deposits noted. There was
extensive fusion of foot processes. The expanded mesangium
contained increased matrix, cells, and finely granular electron
dense deposits (Fig. 2B). Tubuloreticular structures were abun-
dant within the cytoplasm of endothelial cells.
Patient 3. All of the six glomeruli exhibited diffuse mesangial
expansion (Fig. IC). There was a dense mononuclear interstitial
infiltrate consisting mostly of plasma cells. The infiltrating cells
in some instances permeated tubular epithelium, resulting in
destruction of the tubular basement membrane. A few tubules
showed dilation with proteinaceous material within lumina.
Immunofluorescent microscopy showed glomeruli contained
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Fig. 1. Light microscopy of renal biopsies from Patients 1(A), 2
(B), 3 (C), and 4 (D). A shows a glomerulus exhibiting mesangial
expansion with increased cellularity, and tubulointerstitial nephritis
(magnification 160 x). Crescentic proliferation of Bowman's
epithelial cells is seen. B shows a glomerulus exhibiting diffuse
mesangial expansion, and increased cellularity. Severe
tubulointerstitial nephntis is noted (magnification 160 x). C shows
prominent, diffuse mesangial expansion with slight hypercellularity.
Marked tubulointerstitial nephritis is present (magnification 250 x).
D shows a glomerulus exhibiting diffuse increased cellularity and
mesangial expansion (magnification 250 x),
primarily in a mesangial distribution (Fig. 3). Electron micros-
copy revealed one obsolescent glomerulus with scanty electron-
dense deposits, while a second glomerulus showed extensive
segmental approximation of foot processes of visceral epithelial
cells, finely granular electron-dense deposits within mesangial
cells, basement membranes of normal thickness, and variably
sized peripheral subepithelial electron-dense deposits (Fig. 2C).
Tubular reticular structures were present.
Patient 4. Light microscopy revealed two of seven glomeruli
with proliferative changes (Fig. 1D). The remaining glomeruli
showed global or segmental proliferative and sclerosing
changes, with simplification of the glomerular tufts and syn-
echiae. There were many atrophic tubules, with dilated lumina
and flat, vacuolated epithelium, and interstitial edema. Foci of
mononuclear cell collections were seen mostly around venules.
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Fig. 2. Electron micrographs ofglornerular tissue from biopsies of Patients 1(A), 2 (B), 3 (C), and 4 (D). A shows a consolidated segment of tuft
with denuded visceral epithelial cell foot processes and subendothelial deposits (magnification 9,000 X). B shows fused foot processes and
electron-dense deposits within the mesangium (magnification 15,000 x). C shows prominent, variably-sized subepithelial deposits, and scanty
mesangial electron dense deposits. Tubular reticular structures are present (magnification 18,000 x). D shows fusion of foot processes and
intramesangial and subendothelial electron-dense deposits (magnification 17,000 X).
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Fig. 2. Continued.
dilated tubules and resorption droplets. C'3, C' iq, and proper-
din were present in all glomeruli studied in a segmental distri-
bution, as were traces of IgA. No fibrin, IgG, 1gM or IgE was
detected in specific glomerular distribution. Electron micros-
copy (Fig. 2D) showed a glomerulus with collapsed, consoli-
dated loops, with many small and some large subendothelial
deposits within capillaries obliterated by mononuclear cells.
There were extensive, large mesangial electron-dense deposits.
Foot processes were fused. Tubular reticular structures were
appreciated in endothelial cells.
Immunologic studies
Patient 1. The patient's plasma demonstrated the presence of
IgA antibodies reactive with HIV p24 and gp4l antigens in
addition to IgG antibodies which reacted with p24, gp4l, gpl2O
and gpl6O HIV antigens. A single CIC was detected at a level of
73 ig IgO equivalent binding/mi and shown by immunochemi-
cal analysis to be composed of an IgA antibody complexed to
HIV p24 antigen. In addition, dot blot analysis demonstrated
the presence of HIV p24 antigen in the patient's concentrated
urine (Fig. 4). Elution studies on the renal biopsy tissue
demonstrated the presence of IgA associated with a protein
antigen plus trace amounts of IgG. Immunochemical analysis of
this material revealed that the protein was HIV p24 antigen, and
that the IgA, but not the IgG, was reactive with it, forming a
soluble immune complex in vitro, Studies performed on the in
vitro complex showed that it possessed a 3.8-fold enrichment
when compared to circulating levels. This level was confirmed
by the demonstration of a 3.4-fold higher concentration of C'3
in the eluate compared with plasma concentrations. Direct
immunofluorescence of the eluted biopsy material demon-
strated the presence of HIV p18 and p24 antigens within both
glomerular and tubular epithelial cells and sparse staining in the
mesangium (Fig. 5).
Patient 2. Evaluation of Patient 2's plasma demonstrated the
presence of 1gM antibodies reactive with HIV p18 and gp4l
antigens in addition to IgG antibodies which bound to p24,
gp4l, p55, gpl2O and gpl6O HIV antigens. A single CIC was
detected (231 pg IgG equivalent binding/mi). Immunochemical
analysis of this complex showed it was composed of an IgG
antibody complexed to a 120 kDa HIV antigen. Examination of
the patient's concentrated urine by dot blot demonstrated the
presence of both HIV p24 and gpl2O antigens (Fig. 4), together
with a trace of free kappa light chain. Elution studies on the
renal biopsy demonstrated that IgG antibodies against HIV
gpl2O, and HIV gpl2O antigen could be differentially recovered
over time (Fig. 6). Immunochemical analysis revealed the
eluted antibody was reactive with the HIV gpl2O antigen
recovered from the urine and the isolated CIC. A classical line
of identity could be produced when either the eluted antibody
or the antibody isolated from the CIC was reacted with the
antigen from the biopsy elution, the antigen recovered from the
CIC and the antigen recovered from the patient's urine by
immunodiffusion (Fig. 7). Western blot analysis confirmed that
all three antigens were of HIV origin. Reconstitution studies
showed that the 17-hour elution sample contained the equiva-
lent of 1,059 jg IgG equivalent binding/ml, constituting an
approximately 4.5-fold enrichment over circulating levels.
Analysis of C'3 levels in the eluate confirmed a fourfold
increase compared to plasma levels. Direct immunofluores-
cence for the presence of HIV antigens revealed HIV p18 in the
mesangium.
Patient 3. Analysis of the plasma demonstrated the presence
of two circulating immune complexes: one complement-fixing
complex composed of IgG and a 24 kDa protein antigen and a
non-complement-fixing complex composed of 1gM and IgG.
Further analysis of the complement-fixing complex revealed the
protein was HIV p24 antigen and that the IgG was reactive with
HIV p24. Analysis of the non-complement-fixing complex dem-
onstrated that it was composed of an 1gM anti-antibody reactive
against IgG anti-HIV p24 antibody and an anti-HIV p24 IgG
antibody. Examination of the patient's concentrated urine by
dot blot demonstrated the presence of HIV p24 and gpl6o
antigens. Elution studies of the patient's renal biopsy revealed
the presence of HIV p24 antigen and an IgG antibody reactive
against the p24 antigen. Further analysis demonstrated that the
eluted complex was identical to the complement-fixing complex
isolated from the patient's plasma. Enrichment studies showed
a 5.3-fold increase over plasma levels for the immune complex,
confirmed by a 4.8-fold increase in C'3 levels in the eluate
compared to plasma levels. Direct immunofluorescence of the
eluted renal biopsy material demonstrated the presence of HIV
p24 antigen in the mesangium (Fig. 5).
Patient 4. The patient's plasma demonstrated the presence of
a positive anti-HIV ELISA composed of IgA antibodies reac-
tive to p18 and IgG antibodies reactive against p24, gp4l, p55,
gpl2O and gpl6O HIV antigens by Western blot. A single CIC,
at a level of 81 g IgG equivalent binding/mi, was detected by
C' lq assay and isolated by PEG precipitation/sedimentation.
Immunochemical analysis showed this complex to be composed
of an IgG antibody complexed to a 24 kDa HIV antigen. Dot
blot analysis of the urine demonstrated the presence of HIV p24
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Fig. 3. Immunofluorescence photomicrograph oJIgG staining of a glomerulus from Patient 3. A finely granular mesangial and scanty peripheral
pattern is present (magnification approximately 300 x).
antigen (Fig. 4). Elution studies on the renal biopsy demon-
strated only albumin, HIV p24 antigen, and complement prod-
ucts. Examination of the eluted biopsy tissue by direct immu-
nofluorescence showed the presence of HIV p18 and p24
antigens within the mesangium and glomertilar loops.
Western blot analysis of the eluted antibodies from Patients
1, 2, and 3 failed to demonstrate immune reactivity against
CMV, hepatitis B, or syphilis antigens.
Polymerase chain reaction
The reagent control (without DNA template) showed no
amplification of MyHC or HIV-1 gag gene (Fig. 8, lane 1). The
negative control sample containing DNA known to be negative
for HIV target sequences showed amplification of MyHC, but
no amplification of the HIV-l gag gene target sequences (lane
2). The positive control sample showed amplification for MyHC
A B C D
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Fig. 4. Dot blot of concentrated urine samples from all three patients.
Row A represents Patient I, Row B Patient 2 and Row C Patient 4. Row
D is composed of HIV antigen standards (p18, p24, gp4l, p51/56, PS5,
gpl2O, and gpl6O). Rows A, B and C all demonstrate the presence of
HIV p24 antigen in the urine, while Row B also shows the presence of
HIV gpl2O. Data from Patient 3 are not shown.
as well as amplification of the HIV-1 gag gene target sequences
(lanes 3 to 5) but no amplification of MyHC or HIV-1 gene
sequences below 1 copy (lanes 6 and 7). Renal biopsy tissue
from an HIV-negative patient with glomerulonephritis showed
amplification of the MyHC gene, but not the HIV-1 gag target
sequence (lane 8). The renal biopsy specimens of all four
patients with glomerulonephritis and HIV infection showed
amplification of both MyHc and HIV-1 gag genes (lanes 9 to 12).
Amplification of the env gene (not shown) was performed in
Patients I and 2, and was positive in both cases.
Discussion
Although histopathological findings suggestive of immune
complex disease have been reported in patients with renal
disease and HIV infection [1—3, 6, 11—19, 29], the significance of
these disparate pathologic entities has been unclear. The patho-
logical findings described in such cases might be related to
Fig. 5. Laser-enhanced fluorescence photomicrographs of HIV p24
localization in acid-eluted renal biopsy sections. A shows localization
of antigen in a glomerulus from the biopsy of Patient 1, while B shows
localization of HIV p24 in a glomerulus from Patient 3's biopsy.
antigen-antibody complex deposition, occurring as a conse-
quence of immune responses against the infectious agents
which complicate HIV infection. This is possible because of the
polyclonal B-cell activation leading to increased immunoglob-
ulin production in patients with HIV infection [30]. Pathologic
findings have been interpreted as consistent with postinfectious
glomerulonephritis, perhaps a consequence of the infectious
complications of AIDS [12]. Alternatively, HIV-related circu-
lating immune complexes are common in HIV infected patients
at all stages of disease [20—22, 31—40] and have been shown to
play a role in the pathogenesis of immune-mediated thrombo-
cytopenia in HIV-infected patients [41]. Deposition of such
CICs may play a specific pathogenic role in mediating glomer-
ulonephritis associated with HIV infection [42]. We recently
described two patients with HIV infection and IgA nephropathy
in whom CICs composed of IgA idiotypic antibodies reactive
with anti-HIV IgG or 1gM antibodies were isolated. Eluates of
0 1 4 8 17
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Fig. 6. Agarose gel separation of kidney eluate over time (0, 1, 4, 8, and 17 hours after incubation of the eluted solution). Samples were applied
on Whatman 3MM filter paper squares and allowed to migrate into the 2MM gel for 5 minutes before separation. Antibody migrates toward the
top and antigen towards the bottom of the figure. At 1 hour, a faint antibody line, but no antigen is seen. At 4, 8, and 17 hours after incubation,
both antibody and antigen appear in increasing amounts. Example taken from Patient 2.
renal biopsy tissue in one patient contained an identical immune
complex [16].
In the present study, the light and electron microscopic
findings in the patients are consistent with immune complex
mediated glomerulonephritis [42-441. We demonstrated the
presence of circulating antigen-antibody complexes of HIV
p24/anti-HIV p24 IgA and an identical complex which could be
eluted from renal tissue with an appearance typical of immune
complex-mediated glomerulonephritis, in the first patient,
whose glomerulus showed evidence of IgA deposition. An HIV
gpl2O/anti-HIV gpl2O IgG circulating complex was present in
the second patient, and this complex could be recovered from
the renal biopsy eluate even though IgG was found only in the
tubules and not in the single available glomerulus. In Patient 3,
we demonstrated the presence of two circulating immune
complexes, one composed of an IgG antibody complexed to
HIV p24 antigen, and the other composed of an 1gM anti-
antibody complexed to the anti-HIV p24 IgG. Analysis of the
renal biopsy eluate revealed the presence of only the lgG/HIV
p24 complex. In the fourth patient an IgG/HIV p24 antigen
complex could be demonstrated in the plasma, but only the HIV
antigen and complement could be recovered from the renal
biopsy eluate, even though the glomeruli in this biopsy demon-
strated a typical pathological appearance consistent with im-
mune complex-mediated glomerulonephritis. All patients' biop-
sies had evidence of microcystic tubular dilatation, and three of
the four had tubular reticular structures noted on electron
microscopy. In addition, HIV-related antigens were detected in
all four patients' urine and in glomerular cells in the eluted
biopsy tissue. The latter finding was confirmed by our ability to
demonstrate the presence of HIV gag genome in renal paren-
chyma in all four patients but not in renal tissue of other
patients with renal disease in the absence of HIV infection.
The differences in the immunoglobulins detected in the elu-
tion and immunofluorescence studies in two of the patients may
be due to differences in the sensitivities of these techniques.
Analyses of eluates involve dissociation of deposited and in situ
complexes, while immunofluorescence can only detect surface
immune reactants, leaving others masked by steric hindrance
[45].
The role of viruses in the pathogenesis of immune complex
glomerulonephritis has been appreciated for some time. The
several possible pathogenic mechanisms involved in viral in-
duced glomerulonephritis have recently been reviewed [42].
The presence of circulating antigen-antibody complexes, con-
sisting of HIV p24 bound to anti-p24 IgA antibody and anti-p24
IgG antibody, or HIV gpl2O bound to anti-gp 120 IgG antibody
and elution of complexes, composed of the same material, from
renal tissue from the first three patients in higher concentrations
compared to plasma suggests that one mechanism which may
be responsible for the renal disease in our patients is the
deposition or trapping of such complexes. The increased detec-
tion of antibody and antigen over time (Fig. 6) and the results of
enrichment studies, moreover, strengthen the likelihood that
AB.
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Fig. 7. Immunod(fl'usion analysis of immune complex components
isolated from the circulation and renal biopsy material. A. Antibody
from the CIC placed in the central well reacted with urinary antigen
(well 1), CIC antigen (well 2), and antigen eluted from the renal biopsy
tissue (well 3), but not with soluble kidney extract (well 4). The other
two wells contain PBS. B. Antibody from the eluate reacts in an
identical manner. Example taken from Patient 2.
this represents true elution of tissue deposited immune com-
plexes. Our data highlight the association between the histolog-
ical and immunological findings, but, although suggestive of
causality, do not prove that immune complexes caused the
disease.
Alternatively, such disease may be associated with in situ
immune complex formation [42—441. Cohen et al demonstrated
proviral HIV DNA in tubular and glomerular epithelial cells in
two of the four specimens of tissue from HIV infected patients
with glomerulonephritis using in vitro DNA hybridization tech-
niques [46]. They also found such markers in patients with
AIDS without clinically obvious renal disease. However, they
were only able to demonstrate the presence of either HIV core
(p 17, p24) or envelope (gp4l, gpl 20) protein antigens in tubules
in one of their four patients with immune complex glomerulo-
nephritis, but were unable to demonstrate the presence of such
antigens in the glomeruli. Although the reason(s) for this
discrepancy is unclear, it is possible that the minute amounts of
antigen present in the glomeruli were below the detection limits
of the assay system used by these investigators. Concentration
of such substances in tubules or identification by specific
elution techniques may enhance the sensitivity of such analy-
ses. In our study, we were able to detect the presence of
intraglomerular antigen only following a tenfold increase in the
detection limits of our immunofluorescence technique by apply-
ing laser enhanced microscopy coupled to computer-assisted
image analysis.
The role of cellular incorporation of HIV genome products in
the development of renal disease is unknown. Preliminary
evidence suggests HIV may infect renal tissue, specifically
mesangial and endothelial cells, in vitro [47]) as well as epithe-
hal cells [46]. It is possible that viral infection itself or alteration
of cellular proteins might lead to subsequent attachment of
circulating anti-HIV antibodies or complexes (in antibody ex-
cess) to an implanted or transformed antigen, presuming there
are free combining sites available to the antibody [42]. We
recently demonstrated the ubiquitous presence of HIV genome
in glomerular and tubular tissue from HIV infected patients
with and without renal disease [18]. The presence of HIV
genome in renal cells, whether a result of infection of renal cells
or as a consequence of its presence in infiltrating immune cells
would seem to provide the necessary conditions for the implan-
tation or expression of an antigen which might initiate an in situ
mechanism of renal immune complex disease pathogenesis [42].
The nephritogenic antigen might be an HIV gene product in
renal tissue or a transformed cell or cell protein. The data
presented in this paper are consistent with the hypothesis that a
combination of both pathogenic mechanisms may be involved
in the development of renal disease in our patients.
Renal parenchymal viral infection itself, however, may be
crucial to the pathogenesis of specific immune complex renal
disease. The development of glomerulonephritis may be depen-
dent on the renal parenchymal incorporation of human immu-
nodeficiency viral antigens [16, 18, 46] or other viral agents [13,
48, 49], although renal cellular HIV infection alone may not be
a sufficient condition for disease expression. Our recent studies
suggest that a triggering mechanism may be critical to the
expression of renal disease in an HIV-infected patient [18].
Hepatitis B virus X protein, for example, has been shown to
transactivate HIV gene expression in vitro [48]. Renal cellular
responses, therefore, particularly if altered by viral infection,
may be important determinants of the expression of disease [2,
42, 50]. Our present finding of HIV antigens in glomerular cells
in human biopsy tissue is consistent with pathological [46] and
in vitro studies [47], and strengthens the causal association of
HIV infection and glomerulonephritis. Alternatively, the find-
ing of HIV gene products in renal tissue could simply be
markers of HIV infection, or indicators of the severity or stage
of infection. The pathogenic significance of a positive PCR still
remains to be established.
Similarly, the role of genetic [51, 52], immunologic and other
host responses [52] may be crucial in determining renal patho-
logic outcomes. It is of interest that a substantial proportion of
the polyclonal immunoglobulin response in HIV infected pa-
tients is comprised of IgA, and that IgA-containing immune
complexes are prevalent in patients with HIV infection and
AIDS [31—40]. These immune responses may partially explain
the increasing prevalence of IgA nephropathy seen in the HIV
infected population [14—17, 51]. Likewise, gpl2O-anti-gpl2O
Nested PCR with primers to the gag gene detected by liquid hybridization
1 2 3 4 5 6 7 8 9 10 11 12
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Fig. 8. Amplification of HI V-i gag gene and
human cardiac myosin heavy chain gene
(MyHC) by nested PCR. Autoradiograms from
liquid hybridization using SK19 for gag gene
and MyHC3O for MyHC gene as probes. Size
markers are restriction fragments of phage X
174 digested with Had!! restriction
endonuclease. bp: base pair length of the
amplified fragment. Lane 1: reagent control
(without DNA template) showing no
amplification of HIV-l gag gene or MyHC
gene. Lane 2: sample containing DNA known
to be negative for HIV-l gag gene (negative
control) showing amplification of MyHC gene
but no amplification of HIV-1 gag target
sequences. Lanes 3-7: Positive control:
tenfold serial dilutions in decreasing
concentrations (102 to 100 copies of a plasmid
containing a 9 kb fragment of the HIV-1
genome). Dilutions from one hundred copies
to one copy show amplification of HIV- 1 gag
gene in lanes 3 to 5; there was no
amplification below 1 copy (lanes 6 and 7) of
the HIV-l gag gene or of the MyHC gene.
Lane 8: DNA from renal biopsy tissue from
an HIV negative patient with
glomerulonephritis shows no amplification of
the HIV-l gag gene; there was amplification
of the MyHC gene. Lane 9: DNA from renal
4- 1 37bp biopsy tissue from Patient 1 shows
amplification of HIV-l gag gene and the
MyHC gene. Lane 10: DNA from renal
biopsy tissue from Patient 2 showing
amplification of HIV-l gag gene and MyHC
gene. Lane 11: DNA from renal biopsy from
Patient 3 showing amplification of HIV- 1 gag
gene and MyHC gene target sequences. Lane
12: DNA from renal biopsy from Patient 4
showing amplification of HIV- I gag gene and
MyHC gene target sequences.
antibody immune complexes have been shown to modulate
immune cell function, perhaps contributing to nephrogenicity at
the tissue level [53]. It is possible that certain specific immune
responses, perhaps to specific modes of antigen presentation or
specific CICs are more likely to provoke an ongoing renal
inflammatory response. Additionally, the role of concurrent or
intercurrent viral infection in affecting renal responses remains
to be determined [2, 48, 49].
Finally, certain investigators have suggested that racial or
ethnic background may be an important determinant of out-
come in patients with renal disease in the presence of HIV
infection [1—3, 52]. The work of Nochy et al [19] has been
instructive in this regard. These workers demonstrated a rela-
tively high prevalence of immune complex disease in both
Black and White patients with HIV infection and renal disease.
Although there was a 52% prevalence of glomerulonephritis in
White patients, there was a substantial, 21% prevalence of
glomerulonephritis in Black patients. The majority in this latter
group were felt by the investigators to have immune-complex
glomerulonephritis coexistent with focal glomerulosclerosis.
Only one of these patients was an intravenous drug user. In
contrast, six of the sixteen White patients with glomerulone-
phritis in their series used intravenous drugs. The majority were
homosexual, in contrast to the Black patients. The HIV in-
fected population treated at George Washington University
Hospital is roughly equally distributed between Black and
White patients (52). The patients in the present series were all
black, with homosexuality or bisexuality, or sexual transmis-
sion rather than drug use as a risk factor for the development of
HIV infection. It may be that the type of antigen or its
presentation or the presence of intravenous drug use, an
independent risk factor for the development of focal glomeru-
losclerosis in the absence of HIV infection [54], may play
critical roles in determining renal histologic outcomes in spe-
cific subgroups of patients with HIV infection who develop
renal disease. The finding of advanced sclerosis in HIV-infected
patients with glomerulonephritis may be a consequence of final
common pathways leading to a fibrotic response, whether
initiating factors originally incited an inflammatory response, or
an increase in renal matrix production [54]. In HIV associated
renal diseases, it is likely that cytokine mediated mechanisms
[55, 56], associated with the common renal interstitial inflam-
matory cellular infiltrative response, or with renal or systemic
HIV infection, may ultimately mediate fibrotic responses, re-
gardless of the initial histologic pattern.
A substantial proportion of HIV-infected patients with ne-
phrotic syndrome may have glomerulonephritis [18, 19]. Nochy
et al [19] have emphasized that a relatively large proportion of
patients may have coexistent focal glomerulosclerosis and
immune complex disease. The paucity of reported cases of
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glomerulonephntis in HIV infected patients may be a function
of sample selection, since patients with asymptomatic urinary
abnormalities, transient, resolved acute renal failure, or stable,
advanced renal failure and nephrotic syndrome and HIV infec-
tion may not be biopsied as frequently as uninfected patients
with similar clinical features, because of the reluctance to treat
with immunosuppressive medications [13, 16]. The clinical
presentation of three of our four patients was similar to that
reported as typical for classic HIV-associated nephropathy.
Renal biopsy is important in determining the histologic diagno-
sis in patients with HIV infection and renal disease [12, 13, 18,
19]. Patient 3 had a spontaneous improvement in renal function
over two months. Patient 2 had a transient beneficial response
to steroid therapy. Steroid therapy has also been used in
another patient with HIV infection and renal disease with
salutary effects [57]. The role of such therapy could be evalu-
ated in specific controlled trials in HIV infected patients with
renal disease with defined clinical and histologic parameters.
We have demonstrated renal disease associated with HIV
immune complexes and incorporation of both HIV genomic
material and core antigen in renal tissue. Circulating immune
complex deposition and in situ mechanisms of immune-medi-
ated renal disease may underlie the pathogenesis of glomerulo-
nephritis in HIV-infected patients. The term "HIV nephropa-
thy" should not be limited to a single differential diagnostic
possibility, such as focal glomerulosclerosis, without clear
evidence of its pathogenesis.
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